Shattuck Labs (STTK) FCF Margin (2019 - 2025)
Shattuck Labs (STTK) reported FCF Margin of 900.0% for Q3 2025, down 36230.0% year-over-year from N/an in Q3 2024, and down 67.38% quarter-over-quarter from 537.7% in Q3 2024.
Shattuck Labs (STTK) FCF Margin (2019 - 2025) Analysis & Trends
Shattuck Labs (STTK) has 7 years of FCF Margin data on file, last reported at 900.0% in Q3 2025.
- FCF Margin for Q3 2025 came in at 900.0%, down 36230.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 4140.8% (down 291533.0% YoY), and the FY2025 annual result was 3995.3%, down 293650.0% from the prior year.
- FCF Margin retreated to 900.0% in Q3 2025 per STTK's latest filing, from 537.7% in the prior quarter.
- Over five years, FCF Margin peaked at 69.12% in Q4 2021 and troughed at 46554.39% in Q1 2023.
- A 5-year average of 7941.26% and a median of 1449.42% in 2024 frame the typical range for FCF Margin.
- The sharpest annual moves came in 2022 and 2024: FCF Margin plunged 2768141 bps in 2022, then surged 4510497 bps in 2024.
- A 5-year view of FCF Margin shows it stood at 69.12% in 2021, then sank by 9001 bps to 6290.77% in 2022, then soared by 57 bps to 2722.13% in 2023, then jumped by 80 bps to 537.7% in 2024, then sank by 67 bps to 900.0% in 2025.
- Business Quant data shows STTK's FCF Margin at 900.0% in Q3 2025, 537.7% in Q3 2024, and 679.18% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -3.98% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -900.00% |
| Sep 30, 2024 | -537.70% |
| Jun 30, 2024 | -679.18% |
| Mar 31, 2024 | -1,449.42% |
| Dec 31, 2023 | -2,722.13% |
| Sep 30, 2023 | -2,493.73% |
| Jun 30, 2023 | -9,278.00% |
| Mar 31, 2023 | -46,554.39% |
| Dec 31, 2022 | -6,290.77% |
| Sep 30, 2022 | -18,302.36% |
| Jun 30, 2022 | -28,024.00% |
| Dec 31, 2021 | -69.12% |
| Sep 30, 2021 | -988.00% |
| Jun 30, 2021 | -342.59% |
| Mar 31, 2021 | -487.58% |
| Dec 31, 2020 | -1,041.06% |
| Sep 30, 2020 | -487.64% |
| Jun 30, 2020 | 72.08% |
| Mar 31, 2020 | -354.87% |
| Dec 31, 2019 | -254.38% |